About consolidated presence of the life sciences field in Osaka.
While leveraging the strength of Osaka, which is the consolidated presence of life science related companies such as pharmaceutical companies and bio venture companies, as well as excellent research institutions such as Osaka University, National Institutes of Biomedical Innovation, Health and Nutrition, and National Cerebral and Cardiovascular Center, various activities are undertaken in Osaka with all-Osaka industry, academia, and government collaboration.
Consolidated presence of pharmaceutical companies
There are more than 300 pharmaceutical companies in Osaka city, especially in Dosho-machi neighborhood.
Its history dates back to the Edo period. This area used to value “pharmacopoeia” which is the source of medicine and it has monopoly on the distribution of medicines. Therefore, it was called the “town of pharmaceutical ” where this business flourished.
Even after 350 years ago, the headquarters of major pharmaceutical companies of Japan such as Shionogi & Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Sumitomo Dainippon Pharma Co., Ltd., and Takeda Pharmaceutical Co., Ltd. are in Osaka. Osaka Prefecture's pharmaceutical production amount is at the top in the whole country (from the “Annual Statistics of Production by Pharmaceutical Industry (2010)" published by the Health Policy Bureau, Ministry of Health, Labor and Welfare). In this manner, this industry supports the economy of Osaka and it is one of the biggest industrial hubs leading the pharmaceutical industry of Japan.
Major pharmaceutical company's location
History of Osaka's life science
Osaka, in particular the neighborhood of Dosho-machi neighborhood had a monopoly on the distribution of medicines and it was referred to as a “town of pharmaceutical”.
Osaka University President Yamamura (at that time) announced the concept of making “North Osaka a base of life science and developing bio hills”.
National Cardiovascular Center (currently National Cerebral and Cardiovascular Center) (Suita City) was established
Senri Life Science Foundation (currently Public Interest Incorporated Foundation Senri Life Science Foundation) was established.
Osaka University School of Medicine and Hospital relocated from Nakanoshima in Osaka City to the current location (Suita Campus) that was newly constructed. It was integrated with the Research Institute for Microbial Devices Hospital.
“Formation of the international base of life science in Osaka area” was decided as a project.
Saito Biomedical Cluster Concept” was adopted as the "Intellectual cluster creation project" by the Ministry of Education, Culture, Sports, Science and Technology.
National Institutes of Biomedical Innovation (currently National Institutes of Biomedical Innovation, Health and Nutrition) was established (Saito, Ibaraki City)
Certified for regional innovation cluster program (in the beginning, selected for Ministry of Education, Culture, Sports, Science and Technology Intellectual Cluster Creation Project (Phase II))
Osaka Bio Headquarters organization structure was built. Office was set up in Senri Life Science Center Building
“Osaka Bio Strategy" was formulated at the" Osaka Bio Strategy Promotion Council" organized by Industry, Academia and Government (renewed every fiscal year)
Designated as Kansai Innovation International Strategy Special Zone (Life Innovation)
Pharmaceuticals and Medical Devices Agency(PMDA)Kansai Branch was established
The Kansai area is designated as a national strategy special zone as a medical innovation base
Business operator of all zones of Saito Life Science Park was finalized
Japan Agency for Medical Research and Development (AMED) Department of Innovative Drug Discovery and Development West Japan head office was established
Name of Suita switching yard and surrounding area (medical cluster) where National Cerebral and Cardiovascular Center would relocate is decided as “Northern Osaka Healthcare City (popularly referred to as Kento)”
Expanded the functions of Pharmaceuticals and Medical Devices Agency (PMDA) Kansai Branch (so that it can offer various types of counseling regarding pharmaceutical affairs)
With the completion of "Osaka Bio Strategy", we summarize initiatives for 10 years.
“Health and medical industries" is positioned as a field to newly emphasize "Osaka growth strategy”, and set up "Global cluster formation" of that industry as a direction to aim.
Established “Osaka Health and Medical Organization Meeting of responsible person” which consists of responsible person of practical affairs of Osaka Bio Strategy Promotion Council.